ClinicalCodes.org

An online clinical codes repository to improve validity and reproducibility of medical database research

Research article:

Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study

Reference:

Evangelos Kontopantelis, David A Springate, David Reeves, Darren M Ashcroft, Martin Rutter, Iain Buchan, Tim Doran(2015) Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study. Diabetologia, doi: 10.1007/s00125-014-3473-8

Link to fulltext article
Abstract
Background: Observational data have been used to inform target levels for modifiable risk factors in type 2 diabetes but these data are limited by confounding. We aimed to describe the shape of observed relationships between risk factor levels and clinically important outcomes in type 2 diabetes after adjusting for multiple confounders. Methods: We used retrospective longitudinal data on 246,544 adults with type 2 diabetes from 600 practices contributing to the Clinical Practice Research Datalink between 2006 and 2012. Proportional hazards regression models quantified the risks of mortality, microvascular or macrovascular events associated with four modifiable risk factors: glycated haemoglobin (HbA1c), systolic and diastolic blood pressure and total cholesterol, while controlling for numerous patient and practice covariates. Findings: U-shaped relationships were observed between all-cause mortality and levels of the four risk factors. The lowest risks were associated with HbA1c 7.25-7.75%; total cholesterol 3.5-4.5 mmol/L; systolic blood pressure 135-145 mmHg; and diastolic blood pressure 82.5-87.5 mmHg. coronary and stroke mortality related to the four risk factors in a positive, curvilinear way, with the exception of blood pressure which related to coronary deaths in a U-shape. Macrovascular events showed a positive and curvilinear relationship with HbA1c but U-shaped for total cholesterol and systolic blood pressure. Microvascular related to the four risk factors in a curvilinear way: positive for HbA1c and systolic blood pressure but negative for cholesterol and diastolic blood pressure. Interpretation: We identified several relationships which, when considered in the light of relevant trial data, support a call for major changes to clinical practice. Most importantly, our results support trial data indicating that normalisation of glucose and blood pressure can lead to poorer outcomes, which makes a strong case for target ranges for these risk factors rather than target levels.
Author for correspondence
Evangelos Kontopantelis
Email for correspondence
E.Kontopantelis@manchester.ac.uk

Code list: res9: statins_plus_other_ll

9 codes in list

Code Coding system Description Entity type List name multilexcode bnfcode bnfchapter
10172 CPRD_product_code ezetimibe with simvastatin tablets 10mg + 40mg drug res9: statins_plus_other_ll 13203001 02120400/02120200 Statins/Ezetimibe
10183 CPRD_product_code simvastatin with ezetimibe tablets 40mg + 10mg drug res9: statins_plus_other_ll 13211001 02120400/02120200 Statins/Ezetimibe
10206 CPRD_product_code simvastatin with ezetimibe tablets 80mg + 10mg drug res9: statins_plus_other_ll 13212001 02120400/02120200 Statins/Ezetimibe
11815 CPRD_product_code simvastatin with ezetimibe tablets 20mg + 10mg drug res9: statins_plus_other_ll 13210001 02120400/02120200 Statins/Ezetimibe
14219 CPRD_product_code ezetimibe with simvastatin tablets 10mg + 80mg drug res9: statins_plus_other_ll 13205001 02120400/02120200 Statins/Ezetimibe
16186 CPRD_product_code INEGY tablets 10mg + 80mg [M S D] drug res9: statins_plus_other_ll 13208001 02120400/02120200 Statins/Ezetimibe
17059 CPRD_product_code INEGY tablets 10mg + 40mg [M S D] drug res9: statins_plus_other_ll 13204001 02120400/02120200 Statins/Ezetimibe
21020 CPRD_product_code INEGY tablets 10mg + 20mg [M S D] drug res9: statins_plus_other_ll 13202001 02120400/02120200 Statins/Ezetimibe
7552 CPRD_product_code ezetimibe with simvastatin tablets 10mg + 20mg drug res9: statins_plus_other_ll 13201001 02120400/02120200 Statins/Ezetimibe

1 comment has been posted.

June 22, 2015, 5:30 a.m. - David Springate

Combination drugs: Statins plus another lipid-lowering drug

Please log in to leave a comment.